hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 6.00
+0.50 (9.09%)
Jan 22, 2026, 5:08 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 40.82 million as of January 22, 2026. Its market cap has decreased by -67.03% in one year.
Market Cap
40.82M
Enterprise Value
32.24M
Revenue
54.47M
Ranking
n/a
PE Ratio
7.80
Stock Price
6.00
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 40.82M, an increase of 136.82%. That is a compound annual growth rate of 14.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 37.42M | -12.70% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 217.93B |
| GSK plc | 72.86B |
| Haleon | 32.41B |
| Smith & Nephew | 10.28B |
| Convatec Group | 4.51B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 2.00B |
| Genus | 1.90B |